Načítá se...
Early versus deferred treatment for early stage multiple myeloma
BACKGROUND: Early stage multiple myeloma (MM) represents about 20% of MM. Most of the patients are asymptomatic. Thus, it is far less dramatic than advanced disease and may require different treatment strategies. For these patients, it is not clear whether it is better to start chemotherapy right af...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2003
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6485476/ https://ncbi.nlm.nih.gov/pubmed/12535504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004023 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|